Changeflow GovPing Pharma & Drug Safety Cosmetic Compositions for Skin Firming Using Es...
Routine Notice Added Final

Cosmetic Compositions for Skin Firming Using Escin Extracts

Favicon for changeflow.com ChangeBridge: Patent Apps - Pharma (A61K)
Published April 2nd, 2026
Detected April 2nd, 2026
Email

Summary

USPTO published Mary Kay Inc.'s patent application for cosmetic compositions containing escin and botanical extracts for treating sagging, loose skin and improving facial contouring. The application includes methods comprising topical application of compositions with escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, and other plant-based ingredients. This is an informational publication with no regulatory compliance requirements.

What changed

USPTO published patent application US20260090980A1 for Mary Kay Inc., covering cosmetic compositions and methods for treating skin to improve the appearance of droopy, loose, sagging, or flaccid skin and facial contouring. The disclosed compositions include escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, Hedychium coronarium root extract, Argania spinosa oil, Rosmarinus officinalis leaf extract, and Morus alba fruit extract. The application was filed September 22, 2023, and published April 2, 2026.

Patent applications are informational publications and do not create regulatory obligations or compliance deadlines. No action is required from cosmetic manufacturers or other regulated entities. Companies developing similar skin firming or contouring products may wish to review the claims to assess potential intellectual property considerations.

Source document (simplified)

← USPTO Patent Applications

COSMETIC COMPOSITIONS AND METHODS OF USING THE SAME

Application US20260090980A1 Kind: A1 Apr 02, 2026

Assignee

MARY KAY INC.

Inventors

Geetha KALAHASTI

Abstract

The present invention relates generally to methods and compositions useful for treating skin, and in particular to improve the appearance of droopy, loose, sagging, and/or flaccid skin and/or to improve facial contouring. In some aspects, disclosed are methods comprising topically applying to the skin an effective amount of a topical composition comprising escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, Hedychium coronarium root extract, Argania spinosa oil, Rosmarinus officianalis leaf extract, and/or Morus alba fruit extract.

CPC Classifications

A61K 8/9711 A61K 8/4953 A61K 8/922 A61K 8/9789 A61K 8/9794 A61Q 19/08

Filing Date

2023-09-22

Application No.

19113771

View original document →

Named provisions

Abstract CPC Classifications

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260090980A1

Who this affects

Applies to
Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 4411 Retail Trade 3241 Chemical Manufacturing
Activity scope
Cosmetic Formulation Patent Filing
Geographic scope
United States US

Taxonomy

Primary area
Product Safety
Operational domain
Legal
Topics
Consumer Protection Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.